These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30256559)

  • 1. Comparative Analysis of the Effects of 17-Beta Estradiol on Proliferation, and Apoptosis in Hepatocellular Carcinoma Hep G2 and LCL-PI 11 Cell Lines.
    Sanaei M; Kavoosi F; Dehghani F
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2637-2641. PubMed ID: 30256559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
    Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
    J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
    Ng LT; Chiang LC; Lin YT; Lin CC
    Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells.
    Yang J; Yang Y; Tian L; Sheng XF; Liu F; Cao JG
    World J Gastroenterol; 2011 Oct; 17(38):4298-307. PubMed ID: 22090786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Effect of the Histone Deacetylase Inhibitor Valproic Acid on Viability and Apoptosis of the PLC/PRF5 Human Hepatocellular Carcinoma Cell Line.
    Sanaei M; Kavoosi F; Roustazadeh A; Shahsavani H
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2507-2510. PubMed ID: 30256044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
    Ren J; Li G; Zhao W; Lin L; Ye T
    World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone, β-estradiol, and hepatocellular carcinoma: stimulation or inhibition? A comparative effect analysis on cell cycle, apoptosis, and Wnt signaling of HepG2 cells.
    Barjesteh F; Heidari-Kalvani N; Alipourfard I; Najafi M; Bahreini E
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):6121-6133. PubMed ID: 38421409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein and Trichostatin A Induction of Estrogen Receptor Alpha Gene Expression, Apoptosis and Cell Growth Inhibition in Hepatocellular Carcinoma HepG 2 Cells.
    Sanaei M; Kavoosi F; Salehi H
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3445-3450. PubMed ID: 29286617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
    Ren J; Chen GG; Liu Y; Su X; Hu B; Leung BC; Wang Y; Ho RL; Yang S; Lu G; Lee CG; Lai PB
    PLoS One; 2016; 11(4):e0153863. PubMed ID: 27093553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
    Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Genistein and 17-β Estradiol on the Viability and Apoptosis of Human Hepatocellular Carcinoma HepG2 cell line.
    Sanaei M; Kavoosi F; Pourahmadi M; Moosavi SN
    Adv Biomed Res; 2017; 6():163. PubMed ID: 29387674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Des-gamma-carboxy prothrombin (DCP) antagonizes the effects of gefitinib on human hepatocellular carcinoma cells.
    Cui SX; Zhang YS; Chu JH; Song ZY; Qu XJ
    Cell Physiol Biochem; 2015; 35(1):201-12. PubMed ID: 25591763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-[(3-carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells.
    Wu J; Qi D; Wei K; Li J; Chen X; Wang A; Liu W; Xue Q; Qiao L
    Exp Oncol; 2005 Mar; 27(1):52-5. PubMed ID: 15812358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
    Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC
    Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of substituted aromatic heterocyclic sulfonyl hydrazone compounds and in vitro anti-hepatoma activity: preliminary results.
    Wei DC; Pan Y; Wang H; Xu WJ; Chen C; Zheng JH; Cai D
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4720-4729. PubMed ID: 30058713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of LCL161, a Smac mimetic on the proliferation and apoptosis in hepatocellular carcinoma cells].
    Ren K; Ma L; Chong D; Zhang Z; Zhou C; Liu H; Zhao S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):898-904. PubMed ID: 27640787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.
    Shen M; Shi H
    PLoS One; 2016; 11(3):e0151455. PubMed ID: 26982332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic and anti-proliferative effects of 17beta-estradiol and 17beta-estradiol-like compounds in the Hep3B cell line.
    Huang EJ; Wu CC; Huang HP; Liu JY; Lin CS; Chang YZ; Lin JA; Lin JG; Chen LM; Lee SD; Kuo WW; Huang CY
    Mol Cell Biochem; 2006 Oct; 290(1-2):1-7. PubMed ID: 16924424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines.
    Hsu YL; Kuo YC; Kuo PL; Ng LT; Kuo YH; Lin CC
    Cancer Lett; 2005 Apr; 221(1):77-89. PubMed ID: 15797630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of SIRT3 in primary hepatocellular carcinoma and the mechanism of its tumor suppressing effects.
    Liu Y; Liu YL; Cheng W; Yin XM; Jiang B
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):978-998. PubMed ID: 28338198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.